A Legacy of Innovation
Our team boasts over a century of combined research and development experience, leading to our belief that the best way to enhance wellness is by empowering the body’s own mechanisms to protect and heal itself. This guiding philosophy is at the heart of our PB125® supplement, developed using our innovative Nrf2.0® Technology.
Meet Our Visionaries
Dr. Joe McCord
As the founder and visionary force behind Pathways Bioscience, Dr. Joe McCord has an extraordinary legacy of more than 56 years in groundbreaking research. He began his journey with the discovery of the superoxide dismutase enzyme, a significant milestone in the field of oxidative stress. Today, McCord’s enduring mission is to revolutionize wellness and aging through cutting-edge natural dietary supplements, paving the way for a healthier future for all.
Dr. Alan Gao
Co-Founder and Chief Operating Officer Dr. Alan Gao brings extensive expertise in molecular biology, specializing in genomics and the complex analysis of gene expression. His passion lies in exploring the intricacies of aging, inflammation, and oxidative stress. With Pathways Bioscience’s innovative Nrf2.0® Technology at his disposal, Gao is committed to unlocking new insights into health and longevity.
Dr. Brooks Hybertson
As CEO and a trailblazer in the field, Dr. Brooks Hybertson has more than 25 years of research and development experience. He leads Pathways’ research and development efforts, focusing on oxidative stress and Nrf2 transcription factors, and his work on groundbreaking pharmaceutical and dietary supplement agents drives the mission forward. Under Hybertson’s leadership, we are committed to pushing the boundaries of wellness science.
The Path Forward
With such a remarkable team at the helm, we are excited about the future of Pathways Bioscience. Our goal remains steadfast: to support your health journey by harnessing the power of your body’s natural defenses. Thank you for being part of our community, and we look forward to continuing this journey together.
Stay tuned for more updates and insights from our team!
